| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/09/1991 | CA1285879C Pharmaceutical article of manufacture comprising a bisulfite stabilized aqueous solution of 5-aminosalycyclic acid and method |
| 07/09/1991 | CA1285876C Process for sugar-coating solid preparation |
| 07/09/1991 | CA1285874C Injectable sustained release formulation |
| 07/09/1991 | CA1285842C Dispensing system for administering beneficial agent formulation to ruminants |
| 07/06/1991 | CA2033535A1 Method for preparing a dried composition of insulin-like growth factor i |
| 07/04/1991 | DE4000084A1 Intravenoes applizierbare pharmazeutische zubereitung von et18-och(pfeil abwaerts)3(pfeil abwaerts) Intravenously administered pharmaceutical preparation of ET18-och (down arrow) 3 (down arrow) |
| 07/04/1991 | DE3943424A1 Solns. for intravenous nutrition - contg. alpha-keto acids, for patients with kidney conditions, avoids nitrogen cpd. build-up |
| 07/04/1991 | DE3943385A1 Mittel zur transdermalen applikation enthaltend rolipram Means for transdermal administration comprising rolipram |
| 07/04/1991 | CA2029330A1 Stable oral composition of zinc |
| 07/03/1991 | EP0435826A1 Intravenous solutions for epilepsy |
| 07/03/1991 | EP0435811A1 Xanthine derivatives |
| 07/03/1991 | EP0435797A1 Ophthalmic irrigation solution used in medicine for the endothelial protection and corneal preservation |
| 07/03/1991 | EP0435785A1 Magnetisable composite microspheres based on a crosslinked organosilicon polymer, their preparation process and their biological use |
| 07/03/1991 | EP0435726A2 Capsule and caplet combination |
| 07/03/1991 | EP0435684A1 Freeze-dried dosage forms and methods for preparing the same |
| 07/03/1991 | EP0435682A2 The use of inclusion complexes of prostaglandins with cyclodextrins in the treatment of ocular hypertension |
| 07/03/1991 | EP0435450A2 Crystalline sugar alcohol containing uniformly dispersed particulate pharmaceutical compound |
| 07/03/1991 | EP0435436A2 Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals |
| 07/03/1991 | EP0435200A2 Estrogen-containing gel preparation |
| 07/03/1991 | EP0435199A2 Acrylic gel material and acrylic gel preparation |
| 07/03/1991 | EP0434820A1 A nutritive composition and a method for its preparation |
| 07/03/1991 | CN1052605A Filter comprising material obtained by freeze drying, method of preparation and use especially in pharmacy threof |
| 07/03/1991 | CN1052604A Biomembrane adhered medicament prescription and filling technology |
| 07/02/1991 | US5028664 Drug-release controlling coating material for long acting formulations |
| 07/02/1991 | US5028653 Non-agglomerating elastomeric organopolysiloxane particulates produced by polyaddition crosslinking |
| 07/02/1991 | US5028633 Excipient for use in compression molding and process of preparation |
| 07/02/1991 | US5028632 Taste masked medicated pharmaceutical |
| 07/02/1991 | US5028625 Chewable Tablet For Oral Administration |
| 07/02/1991 | US5028600 Novel pharmaceutical composition |
| 07/02/1991 | US5028587 Containing arg-b31 and/or arg2-(b31-32) human insulin; antidiabetic agents |
| 07/02/1991 | US5028435 System and method for transdermal drug delivery |
| 07/02/1991 | US5028434 Drug Delivery |
| 07/02/1991 | US5028433 Readily absorbable drug formulation of NB-818 |
| 07/02/1991 | US5028432 Nonaqueous Matrix of Glyceride and/or Mineral Oil or Paraffin |
| 07/02/1991 | US5028431 Antidermatitis substance |
| 07/02/1991 | US5028430 Delivery systems for the controlled administration of LHRH analogs |
| 07/02/1991 | US5028418 Miconazole, Econazole, Sulconazole |
| 07/02/1991 | US5028417 Containing titanium dioxide |
| 07/02/1991 | US5028415 Poly/epoxysuccinic Acid/ |
| 07/02/1991 | US5028335 Crystal structure, ultrafiltration, biochemical immobilization, from Bacillus cells |
| 07/02/1991 | US5028297 Film-forming evaporation apparatus |
| 07/02/1991 | US5027806 Medication delivery system phase two |
| 07/02/1991 | CA1285490C Stabilized enteric coated acetylsalicylic acid granules and process |
| 07/02/1991 | CA1285489C Process for the preparation of stabilized isosorbide- 5-mononitrate tablets, being also of sustained release, and formulations thus obtained |
| 07/02/1991 | CA1285488C Pharmaceutical formulation containing indomethacin |
| 07/02/1991 | CA1285487C Stable solid preparation of thiol ester derivative |
| 07/02/1991 | CA1285486C Method for production of stable nicorandil preparation |
| 07/02/1991 | CA1285485C Nicorandil-containing preparation for injection |
| 07/02/1991 | CA1285484C Chlorpheniramine therapy |
| 07/02/1991 | CA1285483C Sustained release compositions |
| 07/02/1991 | CA1285482C Sustained-release pharmaceutical preparation |
| 07/02/1991 | CA1285478C Stable composition of interleukin-2 |
| 07/02/1991 | CA1285444C Dispenser with dispersing member for delivering beneficial agent |
| 07/02/1991 | CA1285442C Dosage form with means for governing rate of gas formation |
| 06/30/1991 | CA2033414A1 Capsule and caplet combination |
| 06/29/1991 | CA2031469A1 Use of inclusion complexes of prostaglandins with cyclodextrins in the treatment of ocular hypertension |
| 06/28/1991 | WO1991009859A1 New xanthine derivatives |
| 06/28/1991 | WO1991009622A1 Radiolabeled colloid compositions, their use and process for their preparation |
| 06/28/1991 | CA2033146A1 Magnetizable polysilsesquioxane microspheres; process for preparing the same and their use in biology |
| 06/28/1991 | CA2033145A1 Magnetizable "core-shell" microspheres containing a cured organopolysiloxane; process for preparing the same and their use in biology |
| 06/28/1991 | CA2033144A1 Magnetizable composite microspheres containing a cured polysilsesquioxane; process for preparing the same and their use in biology |
| 06/28/1991 | CA2033118A1 Intravenous solutions for status epileptious |
| 06/27/1991 | WO1991009119A1 Improved alginate microcapsules, methods of making and using same |
| 06/27/1991 | WO1991009079A1 Use of supercritical fluids to obtain porous sponges of biodegradable polymers |
| 06/27/1991 | WO1991008795A2 Improved iontophoretic delivery method |
| 06/27/1991 | WO1991008765A1 Stabilization of k2p pro |
| 06/27/1991 | WO1991008760A1 Improved treatment of autoimmune diseases by aerosol administration of auto antigens |
| 06/27/1991 | WO1991008743A1 Circumvention of human tumor drug resistance |
| 06/27/1991 | WO1991008735A1 Pharmaceutical preparations |
| 06/27/1991 | WO1991008733A1 Stable cream and lotion bases for lipophilic drug compositions |
| 06/27/1991 | WO1991008732A1 Antiperspirant |
| 06/27/1991 | WO1991008716A1 Method of treating the oral cavity with dental floss containing chemotherapeutic agents |
| 06/27/1991 | DE3943541A1 Aluminium magnesium hydroxy fatty acid cpds. |
| 06/27/1991 | DE3942145A1 T-pa-solubilisierung T-pa-solubilization |
| 06/27/1991 | DE3942141A1 K2p pro-stabilisierung K2p pro-stabilization |
| 06/27/1991 | CA2045601A1 Circumvention of human tumor drug resistance |
| 06/26/1991 | WO1991009612A1 Tumor cell growth inhibitor |
| 06/26/1991 | EP0434438A2 Hydrolytically degradable hydrophilic gels and the method for preparation thereof |
| 06/26/1991 | EP0434321A2 Multiple encapsulated sweetener delivery system and method of preparation |
| 06/26/1991 | EP0434088A1 Pharmaceutical compositions containing L-carnitine |
| 06/26/1991 | EP0433624A1 Pharmaceutical compositions for the topical use containing pyridinol carbamate |
| 06/26/1991 | EP0433304A1 Means and method for increasing skin respiration |
| 06/26/1991 | CN1052416A Long lasting flavor release in confectionery compressed tablets with multiple encapsulation system |
| 06/26/1991 | CA2044621A1 Inhibiting agent against the proliferation of tumour cells |
| 06/25/1991 | US5026825 With aminolevulinic acid |
| 06/25/1991 | US5026821 Sustained release, biodegradable; surgical sutures, prostheses |
| 06/25/1991 | US5026772 Lyophilized pharmaceutical composition of neocarzinostatin derivative |
| 06/25/1991 | US5026709 Encapsulation; bronchodilator agent; side effect reduction |
| 06/25/1991 | US5026560 Coated with binder and spraying powder containing drug; low substitutes hydroxypropyl cellulose; hardness; dosage forms of e.g. lansoprazole |
| 06/25/1991 | US5026559 Sustained-release pharmaceutical preparation |
| 06/25/1991 | US5026558 Targeting drugs to hepatocytes in the liver |
| 06/25/1991 | US5026557 Adjuvant composition |
| 06/25/1991 | US5026556 Buprenorphine in carrier comprises lower alkyl diols or triols and a polar lipid |
| 06/25/1991 | US5026555 Coating anticholesterol particles with lecithin, and mixing with a sweetened partially-set water, gelatin and glycerin mixture and flavors |
| 06/25/1991 | US5026546 Stabilized adjuvant suspension comprising dimethyl dioctadecyl ammonium bromide |
| 06/25/1991 | US5026543 Oil-free vaccines |
| 06/25/1991 | US5026397 Implants for living bodies; drug delivery |
| 06/25/1991 | US5026365 Method and apparatus for therapeutically treating immunological disorders and disease states |
| 06/25/1991 | CA1285227C Long lasting dihydropyridine calcium channel blockers |
| 06/23/1991 | WO1991009597A1 Use of a material, the main constituent of which is a triglyceride, as an agent with biological effect on the intestinal mucosa and preparation containing such agent |